29 /100
MEDIUM RISK
Score updated Jul 14, 2026

BXMX — Nuveen S&P 500 Buy-Write Income Fund Dilution Risk Tracker

Track BXMX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BXMX — Get alerts when the score changes →

As of July 14, 2026, Nuveen S&P 500 Buy-Write Income Fund (BXMX) has a DilutionWatch DilutionScore of 29/100, rated MEDIUM dilution risk. Nuveen S&P 500 Buy-Write Income Fund has a market capitalization of $1.38B, 104.17M shares outstanding.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
0
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BXMX.
🔔 Track BXMX — Get forecast alerts →

💹 Market Data

Market Cap$1.38B
Shares Outstanding104.17M
FloatN/A
Cash$585
Debt$24.90M
Short InterestN/A

🏛 Institutional Holdings

32.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track BXMX for full holder detail →

📉 Short Interest

Short Interest58.3K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jan 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for BXMX Shareholders

Nuveen S&P 500 Buy-Write Income Fund (BXMX) has a DilutionScore of 29/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for BXMX shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BXMX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BXMX alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BXMX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BXMX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BXMX
📊 BXMX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BXMX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.